Oxford Innovation Finance is a venture capital fund supporting early-stage companies in biotech and manufacturing. They manage OION, one of the UK's oldest angel investment networks, established in 1994 and merged with Oxford Angel Network in 2020. Their EIS Growth Fund, launched in 2021, has made multiple investments, including Hexigone Inhibitors. They are authorised by the Financial Conduct Authority (FCA, 564525).
